Resources
About Us
PAP Devices Market Size, Share, Forecast, & Trends Analysis by Type [CPAP, BiPAP, APAP, Accessories (Masks, Headgear)], Disease [Obstructive Sleep Apnea, COPD, Respiratory Failure] End User [Hospitals, Home Healthcare Settings] - Global Forecast to 2031
Report ID: MRHC - 104851 Pages: 230 Sep-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours Download Free Sample ReportThe PAP Devices Market is projected to reach $6.97 billion by 2031, at a CAGR of 5.2% from 2024 to 2031. The growth of this market is driven by the increasing prevalence of respiratory and sleeping disorders, the rising geriatric population suffering from respiratory disorders, the introduction of new sleep apnea devices, growing awareness about the adverse impacts of untreated sleep apnea, and favorable reimbursement policies for sleep apnea therapies and devices. However, PAP devices are expensive and not suitable for patients with certain conditions, which restrains the market’s growth.
Furthermore, technological advancements in positive airway pressure (PAP) devices and a rising focus on out-of-hospital healthcare are expected to offer significant market growth opportunities. However, the side effects of PAP devices and the low adherence rate for sleep apnea devices are challenging the market’s growth.
The prevalence of respiratory diseases is rising globally. Respiratory diseases are mainly caused due to smoking, infections, air pollution, dust, and chemicals. Some of the most common respiratory diseases are Chronic Obstructive Pulmonary Disease (COPD), asthma, lung cancer, pulmonary fibrosis, pneumonia, bronchitis, cystic fibrosis, and emphysema. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is among the most common causes of mortality worldwide. In 2020, the disorder accounted for approximately 3.23 million deaths, and low and middle-income countries (LMIC) accounted for 90% of COPD deaths among those below the age of 70.
Additionally, sleep disorders include sleep apnea and insomnia and are caused due to hormones, stress, anxiety, and digestive disorders. According to the National Institutes of Health (NIH), in 2021, 50 to 70 million people in the U.S. had chronic sleep disorders, with 40% of adults reportedly falling asleep during the day at least once a month. Thus, the increasing prevalence of respiratory diseases and sleep disorders has increased the adoption of APAP, CPAP, and BiPAP devices.
Click here to: Get Free Sample Pages of this Report
The aging population is on the rise due to increased life expectancy, improved healthcare, urbanization, and higher income levels, resulting in better survival rates. Aging brings about significant structural changes in the respiratory system, making elderly individuals more susceptible to respiratory diseases. Common symptoms include cough, asthma, COPD, sleep-disordered breathing, and dyspnea, necessitating a systematic approach to diagnosis.
However, elderly patients often face misdiagnosis and improper treatment for respiratory disorders. According to the United Nations, the global proportion of people aged 65 and older is projected to increase from 10% in 2022 to 16% in 2050. Significant annual increases in the elderly population are expected in Northern Africa, Western Asia, Sub-Saharan Africa, Oceania (excluding Australia and New Zealand), and Central and Southern Asia between 2022 and 2050.
Furthermore, according to data published by the World Health Organization (WHO) in 2022, by 2030, one in every six people globally will be 60 years or older, with the population aged 60 and above expected to grow from 1 billion in 2020 to 1.4 billion by 2030, and to 2.1 billion by 2050. This demographic shift will lead to a higher prevalence of respiratory disorders among the elderly, increasing the demand for PAP devices.
Prescription or over-the-counter sleep aids and cognitive behavioral therapy for insomnia (CBT-I) are common treatments for people with sleep insomnia and other sleep disorders. However, neither is completely suitable for many patients. Pharmaceuticals have negative effects and result in addiction, and in many parts of the world, trained cognitive behavioral therapy (CBT-I) clinicians are unavailable or do not have timely appointment availability.
Technological advancements in sleep apnea devices have enabled quieter built-in humidification systems and comfort features, including expiratory pressure modulation, inspiratory support, and pressure ramping. Several PAP technologies have been developed to allow patients to participate in their own care by monitoring adherence. For instance, a PAP device can display the previous night's usage and deliver real-time feedback and guidance.
Thus, technological advancements in PAP devices are creating market growth opportunities.
The preference for out-of-hospital healthcare is rising, particularly evident in the shift of PAP therapy from traditional sleep clinics and hospitals to home settings. Historically, patients underwent overnight sleep studies in clinical environments to diagnose and manage sleep apnea. However, outpatient treatment is often more cost-effective compared to inpatient care, saving patients on expenses such as overnight stays and hospital bills.
PAP devices allow patients to receive treatment conveniently at home, eliminating the need to stay in unfamiliar hospital surroundings. This setup can improve sleep quality and enhance overall treatment adherence. Moreover, the advent of portable PAP devices has empowered patients to self-manage conditions like sleep apnea more effectively. These devices are compact, user-friendly, and equipped with wireless capabilities for data tracking and remote adjustments.
The integration of smart features into PAP devices necessitates a combination of advanced software and hardware components. These devices utilize sophisticated sensors and algorithms to continuously gather data during sleep, which is then presented and analyzed in a user-friendly format.
Furthermore, smart features in PAP devices provide real-time monitoring of mask seal integrity to optimize therapy effectiveness. They also monitor sleep patterns and treatment adherence, enabling the identification of trends and detection of irregularities. This capability facilitates the development of personalized and effective treatment plans, ultimately enhancing patient outcomes.
Based on product, the PAP devices market is segmented into Continuous Positive Airway Pressure (CPAP) devices, Bilevel Positive Airway Pressure (BiPAP) devices, Automatic Positive Airway Pressure (APAP) devices, and accessories. In 2024, the continuous positive airway pressure (CPAP) devices segment is expected to account for the largest share of 68.2% of the PAP devices market. The segment’s large market share is attributed to the availability of advanced noiseless CPAP machines with compact designs and advanced interfaces, technological advancements in PAP devices, and the rising availability & accessibility of new CPAP devices. Additionally, rising healthcare expenditures and increasing disposable incomes in emerging countries are driving the adoption of PAP devices.
Based on application, the PAP devices market is segmented into Obstructive Sleep Apnea (OSA), respiratory failure, Chronic Obstructive Pulmonary Disease (COPD), and heart failure. In 2024, the obstructive sleep apnea (OSA) segment is expected to account for the largest share of the PAP devices market. The segment’s large market share is attributed to the introduction of products for treating obstructive sleep apnea. For instance, in August 2021, ResMed Inc. (U.S.) launched the AirSense 11 PAP Series of devices to manage and treat obstructive sleep apnea. Also, in September 2021, Sommetrics, Inc. (U.S.) ran clinical trials of the aerSleep II device developed for the treatment of obstructive sleep apnea.
Based on end user, the PAP devices market is segmented into hospitals & sleep clinics and home healthcare settings. In 2024, the hospitals & sleep clinics segment is expected to account for the largest share of 60.9% of the PAP devices market. The large market share of this segment is attributed to the rising prevalence of sleep apnea. According to the National Institutes of Health (NIH), in 2020, 936 million adults aged 30–69 suffered from mild to severe obstructive sleep apnea (OSA), and 425 million adults aged 30–69 suffered from moderate to severe obstructive sleep apnea globally.
In 2024, North America is expected to account for the largest share of 41.5% of the PAP devices market, followed by Europe and Asia-Pacific. North America’s significant market share can be attributed to the growing awareness about the adverse impacts of untreated sleep apnea, increasing prevalence of respiratory and sleep disorders, and the presence of major PAP devices companies such as ResMed Inc. (U.S.), Rotech Healthcare Inc. (U.S.), and Cardinal Health, Inc. (U.S.).
However, the market in Asia-Pacific is projected to register the highest growth rate of 5.7% during the forecast period. The growth of this regional market can be attributed to the increasing government spending on healthcare in countries such as China, India, Singapore, and South Korea, technological advancements in PAP devices, and increasing government initiatives to promote awareness. Furthermore, government initiatives supporting the development of healthcare facilities and increasing awareness about sleep disorders and respiratory disorders contribute to the growth of this regional market.
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios and geographic presence and the key growth strategies adopted by them over the past 3–4 years. Some of the key players operating in the PAP devices market are ResMed Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Inspire Medical Systems, Inc. (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Rotech Healthcare Inc. (U.S.), Cardinal Health, Inc. (U.S.), Invacare Corporation (U.S.), Cleveland Medical Devices Inc. (U.S.), BMC Medical Co., Ltd. (China), Löwenstein Medical Technology GmbH + Co. KG. (Germany), SomnoMed, Inc. (Australia), Drive DeVilbiss Healthcare Ltd. (U.S.), and SunMed, LLC (U.S.)
In March 2024, ResMed Inc. (U.S.) launched the AirFit F40 ultra-compact, full-face mask for sleep apnea.
In February 2024, ResMed Inc. (U.S.) launched the AirCurve 11 device, a new bi-level sleep apnea device, as a CPAP alternative to treat patients with sleep apnea.
Particulars |
Details |
Number of Pages |
230 |
Format |
|
Forecast Period |
2024–2031 |
Base Year |
2023 |
CAGR (Value) |
5.2% |
Market Size (Value) |
USD 6.97 billion by 2031 |
Segments Covered |
By Product
By Disease
By End User
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, Sweden, Belgium, Denmark, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa) |
Key Companies |
ResMed Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Inspire Medical Systems, Inc. (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Rotech Healthcare Inc. (U.S.), Cardinal Health, Inc. (U.S.), Invacare Corporation (U.S.), Cleveland Medical Devices Inc. (U.S.), BMC Medical Co., Ltd. (China), Löwenstein Medical Technology GmbH + Co. KG. (Germany), SomnoMed, Inc. (Australia), Drive DeVilbiss Healthcare Ltd. (U.S.), and SunMed, LLC (U.S.) |
This study offers a detailed assessment of the PAP devices market and provides market sizes & forecasts based on product, disease, and end user. This report also involves the value analysis of various segments and subsegments of the PAP devices market at the regional and country levels.
The PAP devices market is projected to reach $6.97 billion by 2031, at a CAGR of 5.2% during the forecast period.
Among the products covered in this report, in 2024, the continuous positive airway pressure (CPAP) devices segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the increasing demand for therapeutic devices & accessories, technological advancements, and the rising availability & accessibility of new CPAP devices. Additionally, rising healthcare expenditures and increasing disposable incomes in emerging countries are increasing the adoption of PAP devices.
Among the diseases covered in this report, in 2024, the obstructive sleep apnea segment is expected to hold the largest share of the market. The large market share of this segment is attributed to the increasing product launches for the treatment of obstructive sleep apnea, initiatives supporting the early diagnosis, screening, and treatment of obstructive sleep apnea, and increasing awareness about the treatment and adverse effects of obstructive sleep apnea.
The growth of this market is driven by the increasing prevalence of respiratory and sleeping disorders, the rising geriatric population suffering from respiratory disorders, the launch of new PAP devices, growing awareness about the adverse impacts of untreated sleep apnea, and favorable reimbursement policies for sleep apnea therapies and devices.
Furthermore, technological advancements in positive airway pressure (PAP) devices are expected to offer significant market growth opportunities.
The key players profiled in the PAP devices market study are ResMed Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Inspire Medical Systems, Inc. (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Rotech Healthcare Inc. (U.S.), Cardinal Health, Inc. (U.S.), Invacare Corporation (U.S.), Cleveland Medical Devices Inc. (U.S.), BMC Medical Co., Ltd. (China), Löwenstein Medical Technology GmbH + Co. KG. (Germany), SomnoMed, Inc. (Australia), Drive DeVilbiss Healthcare Ltd. (U.S.), and SunMed, LLC (U.S.).
Emerging economies, such as China and India, are expected to provide significant growth opportunities for market players due to the increasing adoption of new technologies in these countries.
1. Overview
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Factors Affecting Market Growth
4.1. Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Respiratory and Sleep Disorders
4.2.2. Increasing Geriatric Population Suffering from Respiratory Disorders
4.2.3. Product Launches and Approvals for PAP Devices
4.2.4. Growing Awareness about the Adverse Impacts of Untreated Sleep Apnea
4.2.5. Favorable Reimbursement Policies for Sleep Apnea Therapies and Devices
4.3. Restraints
4.3.1. High Costs of PAP Devices
4.3.2. Unsuitability for Patients with Certain Conditions
4.4. Opportunities
4.4.1. Technological Advancements in PAP Devices
4.4.2. Rising Focus on Out-Of-Hospital Healthcare
4.5. Challenges
4.5.1. Side Effects of PAP Devices
4.5.2. Less Adherence Rate for Sleep Apnea Devices
4.6. Trends
4.6.1. Integration of Smart Features in PAP Devices
4.7. Pricing Analysis
4.8. Regulatory Analysis
4.9. Porter’s Five Forces Analysis
5. Global PAP Devices Market Assessment—by Product
5.1. Overview
5.2. Continuous Positive Airway Pressure (CPAP) Devices
5.3. Bilevel Positive Airway Pressure (BiPAP) Devices
5.4. Automatic Positive Airway Pressure (APAP) Devices
5.5. Accessories
5.5.1. Masks
5.5.1.1. Full Face Masks
5.5.1.2. Nasal Masks
5.5.1.3. Nasal Pillows/Cushion Masks
5.5.2. Headgear
5.5.3. Other Accessories
6. Global PAP Devices Market Assessment—by Disease
6.1. Overview
6.2. Obstructive Sleep Apnea (OSA)
6.3. Respiratory Failure
6.4. Chronic Obstructive Pulmonary Disease (COPD)
6.5. Heart Failure
7. Global PAP Devices Market Assessment—by End User
7.1. Overview
7.2. Hospitals and Sleep Clinics
7.3. Home Healthcare Settings
8. PAP Devices Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U. S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Switzerland
8.3.7 Netherlands
8.3.8. Sweden
8.3.9. Belgium
8.3.10. Denmark
8.3.11. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Rest of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2 Mexico
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. UAE
8.6.3. South Africa
8.6.4. Rest of Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis/Market Rankings (2023)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. ResMed Inc.
10.2. Koninklijke Philips N.V.
10.3. Inspire Medical Systems, Inc.
10.4. Fisher & Paykel Healthcare Corporation Limited
10.5. Medtronic plc
10.6. Rotech Healthcare Inc.
10.7. Cardinal Health, Inc.
10.8. Invacare Corporation
10.9. Cleveland Medical Devices Inc.
10.10. BMC Medical Co., Ltd.
10.11. Löwenstein Medical Technology GmbH + Co. KG.
10.12 SomnoMed, Inc.
10.13 Drive DeVilbiss Healthcare Ltd.
10.14 SunMed, LLC
10.15 Other Companies
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 2 Global Continuous Positive Airway Pressure (CPAP) Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Bilevel Positive Airway Pressure (BiPAP) Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Automatic Positive Airway Pressure (APAP) Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 6 Global PAP Accessories Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 8 Global PAP Masks Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Full Face Masks Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Nasal Masks Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Nasal Pillows/Cushion Masks Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Headgear Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Other Accessories Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 15 Global PAP Devices Market for Obstructive Sleep Apnea (OSA), by Country/Region, 2022–2031 (USD Million)
Table 16 Global PAP Devices Market for Respiratory Failure, by Country/Region, 2022–2031 (USD Million)
Table 17 Global PAP Devices Market for Chronic Obstructive Pulmonary Disease (COPD), by Country/Region, 2022–2031 (USD Million)
Table 18 Global PAP Devices Market for Heart Failure, by Country/Region, 2022–2031 (USD Million)
Table 19 Global PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 20 Global PAP Devices Market for Hospitals and Sleep Clinics, by Country/Region, 2022–2031 (USD Million)
Table 21 Global PAP Devices Market for Home Healthcare Settings, by Country/Region, 2022–2031 (USD Million)
Table 22 Global PAP Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 23 North America: PAP Devices Market, by Country, 2022–2031 (USD Million)
Table 24 North America: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 25 North America: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 26 North America: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 27 North America: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 28 North America: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 29 U.S.: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 30 U.S.: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 31 U.S.: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 32 U.S.: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 33 U.S.: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 34 Canada: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 35 Canada: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 36 Canada: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 37 Canada: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 38 Canada: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 39 Europe: PAP Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 40 Europe: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 41 Europe: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 42 Europe: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 43 Europe: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 44 Europe: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 45 Germany: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 46 Germany: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 47 Germany: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 48 Germany: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 49 Germany: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 50 France: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 51 France: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 52 France: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 53 France: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 54 France: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 55 U.K.: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 56 U.K.: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 57 U.K.: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 58 U.K.: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 59 U.K.: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 60 Italy: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 61 Italy: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 62 Italy: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 63 Italy: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 64 Italy: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 65 Spain: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 66 Spain: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 67 Spain: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 68 Spain: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 69 Spain: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 70 Switzerland: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 71 Switzerland: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 72 Switzerland: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 73 Switzerland: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 74 Switzerland: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 75 Netherlands: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 76 Netherlands: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 77 Netherlands: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 78 Netherlands: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 79 Netherlands: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 80 Sweden: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 81 Sweden: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 82 Sweden: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 83 Sweden: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 84 Sweden: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 85 Belgium: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 86 Belgium: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 87 Belgium: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 88 Belgium: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 89 Belgium: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 90 Denmark: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 91 Denmark: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 92 Denmark: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 93 Denmark: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 94 Denmark: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 95 Rest of Europe: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 96 Rest of Europe: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 97 Rest of Europe: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 98 Rest of Europe: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 99 Rest of Europe: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 100 Asia-Pacific: PAP Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 101 Asia-Pacific: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 102 Asia-Pacific: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 103 Asia-Pacific: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 104 Asia-Pacific: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 105 Asia-Pacific: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 106 Japan: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 107 Japan: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 108 Japan: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 109 Japan: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 110 Japan: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 111 China: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 112 China: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 113 China: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 114 China: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 115 China: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 116 India: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 117 India: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 118 India: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 119 India: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 120 India: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 121 South Korea: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 122 South Korea: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 123 South Korea: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 124 South Korea: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 125 South Korea: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 126 Australia: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 127 Australia: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 128 Australia: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 129 Australia: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 130 Australia: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 131 Rest of Asia-Pacific: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 132 Rest of Asia-Pacific: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 133 Rest of Asia-Pacific: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 134 Rest of Asia-Pacific: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 135 Rest of Asia-Pacific: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 136 Latin America: PAP Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 137 Latin America: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 138 Latin America: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 139 Latin America: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 140 Latin America: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 141 Latin America: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 142 Brazil: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 143 Brazil: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 144 Brazil: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 145 Brazil: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 146 Brazil: PAP Devices Market, by End User, 2022–2031 ((USD Million)
Table 147 Mexico: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 148 Mexico: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 149 Mexico: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 150 Mexico: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 151 Mexico: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 152 Argentina: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 153 Argentina: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 154 Argentina: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 155 Argentina: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 156 Argentina: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 157 Rest of Latin America: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 158 Rest of Latin America: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 159 Rest of Latin America: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 160 Rest of Latin America: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 161 Rest of Latin America: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 162 Middle East & Africa: PAP Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 163 Middle East & Africa: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 164 Middle East & Africa: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 165 Middle East & Africa: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 166 Middle East & Africa: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 167 Middle East & Africa: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 168 Saudi Arabia: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 169 Saudi Arabia: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 170 Saudi Arabia: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 171 Saudi Arabia: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 172 Saudi Arabia: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 173 UAE: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 174 UAE: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 175 UAE: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 176 UAE: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 177 UAE: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 178 South Africa: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 179 South Africa: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 180 South Africa: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 181 South Africa: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 182 South Africa: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 183 Rest of Middle East & Africa: PAP Devices Market, by Product, 2022–2031 (USD Million)
Table 184 Rest of Middle East & Africa: PAP Accessories Market, by Type, 2022–2031 (USD Million)
Table 185 Rest of Middle East & Africa: PAP Masks Market, by Type, 2022–2031 (USD Million)
Table 186 Rest of Middle East & Africa: PAP Devices Market, by Application, 2022–2031 (USD Million)
Table 187 Rest of Middle East & Africa: PAP Devices Market, by End User, 2022–2031 (USD Million)
Table 188 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global PAP Devices Market, by Product, 2024 VS. 2031 (USD Million)
Figure 8 Global PAP Devices Market, by Disease, 2024 VS. 2031 (USD Million)
Figure 9 Global PAP Devices Market, by End User, 2024 VS. 2031 (USD Million)
Figure 10 Global PAP Devices Market, by Geography
Figure 11 Impact Analysis: PAP Devices Market
Figure 12 Market Dynamics: PAP Devices Market
Figure 13 Global PAP Devices Market, by Product, 2024 VS. 2031 (USD Million)
Figure 14 Global PAP Devices Market, by Disease, 2024 VS. 2031 (USD Million)
Figure 15 Global PAP Devices Market, by End User, 2024 VS. 2031 (USD Million)
Figure 16 Global PAP Devices Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 17 North America: PAP Devices Market Snapshot
Figure 18 Europe: PAP Devices Market Snapshot
Figure 19 Asia-Pacific: PAP Devices Market Snapshot
Figure 20 Latin America: PAP Devices Market Snapshot
Figure 21 Middle East & Africa: PAP Devices Market Snapshot
Figure 22 Key Growth Strategies Adopted by Leading Players, 2021–2024
Figure 23 PAP Devices Market: Competitive Dashboard
Figure 24 PAP Devices Market: Competitive Benchmarking, by Product
Figure 25 PAP Devices Market: Competitive Benchmarking, by Geography
Figure 26 Market Share Analysis: Global PAP Devices Market, 2023
Figure 27 ResMed Inc.: Financial Overview (2023)
Figure 28 Koninklijke Philips N.V.: Financial Overview (2023)
Figure 29 Inspire Medical Systems, Inc.: Financial Overview (2023)
Figure 30 Fisher & Paykel Healthcare Corporation Limited: Financial Overview (2023)
Figure 31 Medtronic plc: Financial Overview (2023)
Figure 32 Cardinal Health, Inc.: Financial Overview (2023)
Figure 33 Invacare Corporation: Financial Overview (2023)
Figure 34 SomnoMed, Inc.: Financial Overview (2023)
Published Date: Nov-2024
Published Date: Aug-2024
Published Date: Aug-2024
Published Date: Jun-2024
Published Date: Jun-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates